| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 01/21/2010 | US20100015150 Tdf-related compounds and analogs thereof |
| 01/21/2010 | US20100015136 Camptothecin-peptide conjugates and pharmaceutical compositions containing the same |
| 01/21/2010 | US20100015087 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 01/21/2010 | US20100015070 Use of natural, recombinant and synthetic resilins in cosmetics |
| 01/21/2010 | US20100015058 Radiolabeled bbn-rgd heterodimers for cancer targeting |
| 01/21/2010 | CA2730933A1 Recombinant pokeweed antiviral proteins, compositions and methods related thereto |
| 01/21/2010 | CA2730686A1 Anti-amyloid immunogenic compositions, methods and uses |
| 01/21/2010 | CA2730663A1 Anticancer compounds |
| 01/21/2010 | CA2729188A1 Method for producing intermediates for the production of novel macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereof, and uses of said macrocycles |
| 01/20/2010 | EP2145962A2 Process for the manufacture of eptifibatide |
| 01/20/2010 | EP2145898A1 Anti-amyloid immunogenic compositions, methods and uses |
| 01/20/2010 | EP1946109B1 Method for detecting autoantibodies formed in rheumatoid arthritis |
| 01/20/2010 | EP1809653B1 Substituted nonadepsipeptides |
| 01/20/2010 | EP1487493B1 Conjugates of cytotoxic agents and biologically active peptides |
| 01/20/2010 | CN100582782C Plasma urotensin in human heart failure |
| 01/19/2010 | US7649080 Reacting vancomycin with a coupling reagent, then reacting with a cephalosporin derivative; making antibiotic effective against antibiotic-resistant strains of bacteria, such as methicillin-resistant Staphylococci aureus (MRSA) |
| 01/19/2010 | US7648703 Combination of anti-EP-CAM antibody with a chemotherapeutic agent |
| 01/19/2010 | CA2551157C Novel kappa receptor selective opioid peptides |
| 01/14/2010 | WO2010006117A2 Cyclosporin derivatives for treating ocular and dermal diseases and conditions |
| 01/14/2010 | WO2010005925A2 Method and system for generating protein sequence alignments |
| 01/14/2010 | WO2010005693A1 Cyclized ngr peptide compounds, compositions, and methods of their use |
| 01/14/2010 | WO2010005293A1 Peptidylarginine deiminase (pad) inhibitors |
| 01/14/2010 | WO2010005123A1 Composition for enhancing biosynthesis of hyaluronic acid or glycosaminoglycan comprising orotic acid, a salt thereof, or a derivative thereof |
| 01/14/2010 | WO2010004962A1 Method for detection of fibromyalgia |
| 01/14/2010 | WO2010004214A1 Protein disulfide isomerase assay method for the in vitro diagnosis of colorectal cancer |
| 01/14/2010 | WO2010003231A1 Multi-leu peptides and analogues thereof as selective pace4 inhibitors and effective antiproliferative agents |
| 01/14/2010 | WO2010003193A1 Peptide inhibitors of cd40l signaling and uses therefor |
| 01/14/2010 | WO2002072609A9 Neuroactive peptides for prevention and/or treatment of hypoxia and neuropathic pain |
| 01/14/2010 | US20100009923 Antigens Targeted by Pathogenic Al4 T Cells in Type 1 Diabetes and Uses Thereof |
| 01/14/2010 | US20100009922 Hypotensive peptides from soy proteins and method of preparation |
| 01/14/2010 | US20100009920 Ttk as tumor marker and therapeutic target for lung cancer |
| 01/14/2010 | US20100009919 Apolipoprotein A1 Mimetics and Uses Thereof |
| 01/14/2010 | US20100009909 Peptides binding the phosphatase 2a protein |
| 01/14/2010 | US20100009907 Glucagon-Like Peptides and Uses Thereof |
| 01/14/2010 | US20100009857 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries |
| 01/14/2010 | US20100009446 Biologically active molecules, particularly based on pna and sirna, method for the cell-specific activation thereof, and application kit to be administered |
| 01/14/2010 | US20100009397 Substrate-mimetic akt inhibitor |
| 01/14/2010 | US20100008940 Peptide analogs capable of enhancing stimulation of a glioma-specific ctl response |
| 01/14/2010 | US20100008936 IL-16 antagonist peptides and DNA encoding the peptides |
| 01/14/2010 | US20100008920 Reagents and Methods for Engaging Unique Clonotypic Lymphocyte Receptors |
| 01/14/2010 | US20100008855 Production and Use of Novel Peptide-Based Agents with Bispecific Antibodies |
| 01/14/2010 | CA2732676A1 Protein disulfide isomerase assay method for the in vitro diagnosis of colorectal cancer |
| 01/14/2010 | CA2730108A1 Cyclosporin derivatives for treating ocular and dermal diseases and conditions |
| 01/14/2010 | CA2729937A1 Fibromyalgia test method |
| 01/14/2010 | CA2728351A1 Peptidylarginine deiminase (pad) inhibitors |
| 01/14/2010 | CA2727574A1 Multi-leu peptides and analogues thereof as selective pace4 inhibitors and effective antiproliferative agents |
| 01/13/2010 | EP2143734A1 The functional epitope of osteopontin, the anti-osteoponin monoclonal antibody and use thereof |
| 01/13/2010 | EP2142562A2 Stitched polypeptides |
| 01/13/2010 | EP1805203B1 On-resin peptide cyclization |
| 01/13/2010 | EP1499886B1 Methods and compositions for inducing an immune response |
| 01/13/2010 | EP1360500B1 Methods for selective targeting |
| 01/13/2010 | CN101624418A Method for preparing nosiheptide powder |
| 01/13/2010 | CN100579984C Orally administered peptides to ameliorate atherosclerosis |
| 01/12/2010 | US7645741 IAP BIR domain binding compounds |
| 01/12/2010 | US7645740 Peptide sequence found in Laminin 5 for treating skin impairments |
| 01/07/2010 | WO2010003053A2 Hsv-2 peptides for stimulation of cytotoxic t lymphocytes |
| 01/07/2010 | WO2010002976A2 Enzyme-cleavable dye-containing fluor-quencher constructs |
| 01/07/2010 | WO2010002428A2 Novel macrocyclic peptides |
| 01/07/2010 | WO2010002042A1 Enzyme substrate for labeling of protein |
| 01/07/2010 | WO2010000601A1 Synthetic pathway enzymes for the production of argyrins |
| 01/07/2010 | WO2010000592A2 Cyclopeptides used as mmp-type protease enzyme inhibitors |
| 01/07/2010 | WO2010000591A2 Fluorescent cyclic peptides, methods for the preparation thereof, and use of said peptides for measuring the enzymatic activity of a protease enzyme |
| 01/07/2010 | WO2010000493A2 Inorganic-binding peptides and quality control methods using them |
| 01/07/2010 | WO2009117480A3 Histidine related compounds for identifying and blocking amyloid beta ion channels |
| 01/07/2010 | US20100004180 Agents for the Detection and Modulation of B-Cells and Antibodies |
| 01/07/2010 | US20100004179 Targeting of ews-fli1 as anti-tumor therapy |
| 01/07/2010 | US20100004175 Novel bmp-12-related proteins and methods of their manufacture |
| 01/07/2010 | US20100004165 Novel Protein Transduction Domains and Uses Therefor |
| 01/07/2010 | US20100003305 Biocompatible and biodegradable elastomeric polymers |
| 01/07/2010 | US20100003281 antigenic determinant comprising a polypeptide sequence from hepatitis E virus open reading frame 2 ; drug screening |
| 01/07/2010 | US20100003263 Monoclonal antibodies to anthrax protective antigen |
| 01/07/2010 | US20100003244 Agents which bind to epitopes of glycoprotein vi |
| 01/07/2010 | US20100003241 Agents for treatment or prevention of an allergic disorder |
| 01/07/2010 | US20100003234 Cellulase activity; used to make bioethanol, in food and textile treatment, in waste treatment; breaks down lignocellulose |
| 01/07/2010 | US20100003214 Quinoxaline-containing compounds as hepatitis c virus inhibitors |
| 01/07/2010 | US20100003195 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
| 01/07/2010 | CA2726297A1 Synthetic pathway enzymes for the production of argyrins |
| 01/07/2010 | CA2724523A1 Novel macrocyclic peptides |
| 01/06/2010 | EP2141242A1 Synthetic pathway enzymes for the production of Argyrins |
| 01/06/2010 | EP2141175A1 Process for synthesizing cyclic peptide compound |
| 01/06/2010 | EP2140273A2 Diagnostic assay |
| 01/06/2010 | EP1461073B1 Peptide agonists of prostate-specific antigen, and uses therefor |
| 01/06/2010 | EP1404877B1 Assays for preimplantation factor and preimplantation factor peptides |
| 01/06/2010 | CN101619093A Polypeptide with function of promoting activity of fibroblast growth factor receptor 3 and screening method and application thereof |
| 01/06/2010 | CN101619092A Tumor antigen TRAG-3 mimotope peptide and application thereof |
| 01/06/2010 | CN100577682C Method for designing and preparing small peptide |
| 01/06/2010 | CN100577206C Controlled release composition and method of producing the same |
| 01/05/2010 | US7642342 Generate immune response by activation of a T cell or a B cell to claimed peptide, nucleotide expressed in a viral vector; vaccinia, fowlpox, canarypox, adenovirus, influenza, poliovirus, adeno-associated virus, lentivirus, Sindbis virus; diagnostic and therapeutic applications |
| 01/05/2010 | US7642244 Neuropeptide-2 receptor (Y-2R) agonists and uses thereof |
| 01/05/2010 | US7642243 Administering C-type natriuretic peptide, guanyl cyclase (GC-B)-activating peptide |
| 01/05/2010 | US7642235 Macrocyclic peptides active against the hepatitis C virus |
| 01/05/2010 | US7642231 Neo-tryptophan |
| 01/05/2010 | US7642051 Induction of mitochondrial membrane permeabilization via the physical and functional interaction of the HIV-1 Vpr protein with the mitochondrial inner membrane protein ANT (also called adenine nucleotide translocase or ADP/ATP carrier) |
| 01/05/2010 | US7641895 Peptides for active anti-cytokine immunization |
| 01/05/2010 | CA2318192C .beta.2-adrenergic receptor agonists |
| 01/05/2010 | CA2281877C Psca: prostate stem cell antigen |
| 01/05/2010 | CA2202496C Neurotrophic peptides of activity dependent neurotrophic factor |
| 01/05/2010 | CA2062763C Cytokine synthesis inhibitory factor, antagonists thereof, and methods of using same |
| 12/31/2009 | US20090326199 IFBM's to Promote the Specific Attachment of Target Analytes to the Surface of Orthopedic Implants |
| 12/31/2009 | US20090326197 interfacial biomaterial (IFBM); coating to promote osteointegration of the implant, accelerating healing; includes peptide that binds to the surface of the implant, and to e.g. bone morphogenic proteins |